Glenmark Pharmaceuticals Ltd
₹2260
(0.62%)
Fri, 16 Oct 2026, 05:35 am
Health Technology
Pharmaceuticals: Major
24.5KGlenmark Pharmaceuticals Share Price Live Chart
1 Day
(0.62%)
No Result Found
Summary
Market Cap (in Cr)
64403.67
Net Profit (in Cr)
1047.14
P/B
5.73
Sector P/E
36.69
P/E
44.20
EV/EBITDA
21.55
Debt/Equity (Industry)
0.19
Interest Cover (Industry)
13.14
ROCE (Industry)
12.29
RONW (Industry)
10.69
ROE
15.79
ROCE
18.48
Debt/Equity
0.22
EPS (TTM)
110.59
Dividend Yield
0.22
Book Value
372.47
Interest Cover
9.56
Shareholding
| Shareholders | JUN 2026 | MAR 2026 | DEC 2025 | SEPT 2025 | JUN 2025 |
|---|---|---|---|---|---|
| Promoters | 46.65 | 46.65 | 46.65 | 46.65 | 46.65 |
| FII | 20.89 | 20.34 | 19.20 | 20.73 | 20.62 |
| DII | 18.60 | 19.29 | 20.09 | 18.61 | 17.64 |
| Public | 13.81 | 13.68 | 14.02 | 13.97 | 15.06 |
| Government | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 |
Technical Analysis
Support and Resistance
| Type | R3 | R2 | R1 | PP | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | 2779.67 | 2576.77 | 2455.73 | 2373.87 | 2252.83 | 2170.97 | 1968.07 |
| Fibonacci | 2576.77 | 2499.26 | 2451.37 | 2373.87 | 2296.36 | 2248.47 | 2170.97 |
| Camarilla | 2390.50 | 2371.90 | 2353.30 | 2373.87 | 2316.10 | 2297.50 | 2278.90 |
Pivots Level: Classic
R3
+405.80
2779.67
R2
+202.90
2576.77
R1
+81.87
2455.73
S1
-121.03
2252.83
S2
-202.90
2170.97
S3
-405.80
1968.07
Moving Average
Period
Value
10-EMA
2275.78
20-EMA
2312.45
30-EMA
2329.11
50-EMA
2332.43
100-EMA
2300.52
200-EMA
2209.63
Corporate Actions
| Announcement Date | Purpose | Action | Ex Date |
|---|---|---|---|
| 31 Jul 2026 | agm | ||
| 29 May 2026 | board-meetings | Accounts, Final Dividend | |
| 29 May 2026 | dividend | ₹2.50 Dividend /Share | 31 Aug 2026 |
| 30 Jan 2026 | board-meetings | Quarterly Results | |
| 14 Nov 2025 | board-meetings | Quarterly Results | |
| 26 Sept 2025 | dividend | ₹2.50 Dividend /Share | 03 Oct 2025 |
| 03 Sept 2025 | dividend | Interim Dividend - Rs. - 2.5 | 03 Oct 2025 |
| 22 Aug 2025 | agm | ||
| 15 Aug 2025 | dividend | Final Dividend - Rs. - 2.5 | 15 Sept 2025 |
| 23 May 2025 | dividend | ₹2.50 Dividend /Share | 15 Sept 2025 |
Peer Comparison
Glenmark Pharmaceuticals Ltd
Sun Pharmaceutical Industries Ltd
Dr Reddys Laboratories Ltd
Torrent Pharmaceuticals Ltd
Divis Laboratories Ltd
Cipla Ltd
Glenmark Pharmaceuticals Ltd About
Glenmark Pharmaceuticals is primarily engaged in the business of development, manufacturing and marketing of pharmaceutical products. The Company's research and development facilities are located at Mahape, Sinnar and Taloja and manufacturing facilities a
Industry
Pharmaceuticals - Indian - Bulk Drugs & Formln
Founded
1977
Headquarters
CEO
Glenn Saldanha
Employees
Contact
Website
http://www.glenmarkpharma.com
complianceofficer@glenmarkpharma.com
Phone
91-22-40189999
Location
B/2 Mahalaxmi Chambers, 22 Bhulabhai Desai Road, Mumbai, Maharashtra, 400026
Glenmark Pharmaceuticals Ltd Company History
| Year | History |
|---|---|
| 2020 |
|
| 2021 |
|
| 2022 |
|
| 2023 |
|
| 2024 |
|
Deals
| Client Name | Deal Type | Order Side | QTY | Avg Price | Date |
|---|---|---|---|---|---|
| GRAVITON RESEARCH CAPITAL LLP | bulk | Sell | 1510591 | 2173.31 | 11 Jul 2025 |
| GRAVITON RESEARCH CAPITAL LLP | bulk | Buy | 1510591 | 2171.67 | 11 Jul 2025 |
| UBS AG | block | Sell | 264465 | 1492.65 | 25 Mar 2025 |
| INTEGRATED CORE STRATEGIES (ASIA) PTE. LTD. | block | Buy | 264465 | 1492.65 | 25 Mar 2025 |
| UBS AG | block | Buy | 671394 | 1510 | 23 Jan 2025 |
| UBS PRINCIPAL CAPITAL ASIA LIMITED | block | Sell | 671394 | 1510 | 23 Jan 2025 |
| ISHARES CORE MSCI EMERGING MARKETS ETF | block | Buy | 302621 | 397.9 | 25 Oct 2022 |
| ISHARES MSCI INDIA SMALL-CAP ETF | block | Buy | 39265 | 397.9 | 25 Oct 2022 |
| ISHARES INDIA SC MAURITIUS COMPANY | block | Sell | 39265 | 397.9 | 25 Oct 2022 |
| ISHARES CORE EMERGING MARKETS MAURITIUS CO | block | Sell | 302621 | 397.9 | 25 Oct 2022 |
Frequently Asked Questions
1.What is the stock price of Glenmark Pharmaceuticals Ltd?
As of 16/10/2026 at 11:05 AM, Glenmark Pharmaceuticals Ltd shares are trading at ₹2260.
2.What is the market cap. of Glenmark Pharmaceuticals Ltd?
As of 16/10/2026, the market capitalization of Glenmark Pharmaceuticals Ltd is ₹63,980.34 crore.
3.When was Glenmark Pharmaceuticals Ltd founded?
Glenmark Pharmaceuticals Ltd was founded in 1977.
4.What are the P/E and P/B ratios of Glenmark Pharmaceuticals Ltd?
As of 16/10/2026, Glenmark Pharmaceuticals Ltd has a P/E ratio of 35.48 and a P/B ratio of 5.73.
5.How can I buy shares of Glenmark Pharmaceuticals Ltd?
You can buy shares of Glenmark Pharmaceuticals Ltd through Pocketful. Simply open a Demat account, complete your KYC, add funds, and place a buy order.
6.What is the shareholding pattern of Glenmark Pharmaceuticals Ltd?
As of June,2026, promoters hold 46.65% in Glenmark Pharmaceuticals Ltd, while FIIs, DIIs and public shareholders hold 20.89%, 18.60% and 13.81%, respectively. The government holds 0.04%.
7.Does Glenmark Pharmaceuticals Ltd pay dividends?
Yes, Glenmark Pharmaceuticals Ltd pays dividends to eligible shareholders. The latest dividend announced by the company was ₹₹2.50 Dividend /Share per share.
8.What is the dividend yield of Glenmark Pharmaceuticals Ltd?
As of 16 October, 2026, the dividend yield of Glenmark Pharmaceuticals Ltd stands at 0.22%.
9.What are the latest financial results of Glenmark Pharmaceuticals Ltd?
For January,2024, Glenmark Pharmaceuticals Ltd reported revenue of ₹13,322.00 crore and a net profit of ₹1,047.00 crore.
10.What is the Stock symbol of Glenmark Pharmaceuticals Ltd?
GLENMARK is the stock symbol of Glenmark Pharmaceuticals Ltd.
11.Who is the CEO of Glenmark Pharmaceuticals Ltd?
The CEO of Glenmark Pharmaceuticals Ltd is Glenn Saldanha.
